A new site has been opened for the
#AVCT AVA6103 trial.
When you already have ~7 weeks of clinical data, expanding site activity is a VERY positive sign.
For P1A, that’s what you’d expect if:
1. Activation timelines are progressing properly.
2. Enrolment is expanding.
3. They're prepping to move through escalation cohorts efficiently.
A HUGE update just before the weekend 👌
clinicaltrials.gov/study/NCT…